WHO, World Bank Endorse IMF Call for $50 Billion to Fight Virus
(Bloomberg) -- The World Health Organization, World Bank and World Trade Organization endorsed the International Monetary Fund's call to invest $50 billion to fight Covid-19 by making and delivering vaccines and treatments.
“Governments must act without further delay or risk continued waves and explosive outbreaks of Covid-19 as well as more transmissible and deadly virus variants undermining the global recovery,” the four organizations said in a joint statement on Tuesday.
Read more: IMF Backs $50 Billion Plan to Help World Escape Covid Crisis
The IMF last month proposed the spending plan, which targets immunizing at least 40% of the global population by the end of this year -- up from the 30% goal set by the WHO's Covax vaccine initiative -- and 60% or more by the first half of 2022. The groups on Tuesday called for the immediate donation of vaccine doses to developing countries.
The plan will require additional financing for low- and middle-income countries, with much of it coming from grants and below-market-rate loans, the groups said. It also entails investing to boost vaccine production capacity by at least one billion doses, increasing output in regions and countries that at present make little.
The blueprint also urges boosting testing and tracing, oxygen supplies and public health measures, while ramping up vaccination, and the work of the Access to Covid-19 Tools Accelerator, the campaign led by the WHO and others.
The IMF says the plan will save lives and deliver a potential $9 trillion economic boost by 2025.
Separately, IMF members are moving toward approving $650 billion in new reserve assets by the end of August to boost resources for nations, while the World Bank will have vaccine projects up and running in at least 50 countries by mid-year.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.